Ruti Aga and the Six-Year Ban: The Fake Prescription Cost More Than the Drug

The clinic named on the prescription does not exist. The person who signed beneath its stamp holds no medical licence number. And the prescription pad cited in the explanation — according to the account given — was an old pad from a workplace whose personnel records confirm the signatory never worked there. Three layers of verification, three collapses.

That is the entire file the Athletics Integrity Unit assembled before handing down a six-year ban to Ruti Aga, the Ethiopian marathoner, aged 32. This case will be remembered for its smaller details rather than for the name of the substance: a phantom clinic, a “doctor” from inside the family, an old prescription pad. That is the raw material of a news story, and also the raw material of a sanction.

Aga is no random name. She won the 2026 Tokyo Marathon — one of the six World Marathon Majors — and finished runner-up at World Marathon Majors three times. In the women's marathon field between 2026 and 2026, that is an elite résumé, not a reserve one.

The case began at a race in China: Aga won a half marathon in March. Her sample returned an adverse finding for methylprednisolone. She explained that she was being treated for a knee injury. During results management, a prescription was produced to demonstrate a medical indication. The AIU checked that prescription, and the case turned sharply.

The outcome: a six-year ban running from 10 September. Her result at the Chinese half marathon is almost certainly annulled, and the prize money with it.

The number has to be taken apart before any moral argument begins. Six years is not a single penalty. It is two years for the presence of a prohibited substance, plus four years for the fabrication of evidence, served consecutively rather than concurrently — the baseline rule of the WADA Code: multiple independent violations run back to back. Put plainly, the cover-up was punished twice as hard as the original offence. The portion of the sentence attached to the fake prescription is longer than the portion attached to the substance in her sample. That is the most important technical fact of the whole case, and it is the one most summaries skip when they label this a “six-year doping ban”.

One correction is needed, because many outlets got it wrong: methylprednisolone is a synthetic glucocorticoid — a corticosteroid — not an anabolic steroid. It sits in WADA class S9, prohibited in-competition only, and it is a Specified Substance — a category the Code accepts as more plausibly linked to inadvertent use or genuine treatment than other classes. That classification is not academic: it sets the two-year baseline, and it opens a mitigation route Aga threw away.

Had the case stopped at the substance, the story might have ended differently. A real knee injury, an intra-articular indication, a legitimate treatment pathway — that is the scenario the WADA Code still leaves open: apply for a TUE, a Therapeutic Use Exemption, at the right time and through the right process. Without a TUE, in-competition use remains a violation, but the sanction can stop at two years, or lower still if no intent to cheat can be shown.

Instead, the defence file was forged. Tampering during results management is an independent violation with its own baseline, regardless of whether the underlying substance was genuinely therapeutic. The true value of a contract is not in the release clause; it is in the clauses people rush past. Here, the clause left blank was the TUE. What was filled into that blank was a clinic that does not exist.

The AIU's verification followed standard procedure: direct contact with the named medical facility, cross-checks against professional registration numbers, checks on employment history. The facility denied the prescription. The personnel records denied the signatory. No evidentiary gap was left to argue over.

On the career side, the arithmetic is cold. Aga is 32, sitting at the top of the age curve for women's marathoners, a window many athletes hold into their mid-thirties. A six-year ban returns her to eligibility at 38. In theory, women's marathoners still race well at that age. In practice, after six years without competition, without scheduling, without access to the race circuit, a return to Major podium level is close to impossible. This is not a suspended sentence. It is a career-ending one.

There is a layer of damage rarely discussed. In the notebook where I track Asian road races with East African entrants, the main income stream for elite marathoners is not prize money but appearance fees. That market runs on a continuous race calendar and on personal reputation. A six-year ban shuts both. It does not merely erase a result; it erases the invitations.

The counter-intuitive reading is this: the public tends to read cases like this as evidence of a doping system. The AIU file shows something close to the opposite. A phantom clinic, an old pad, a relative playing doctor — those are the marks of ignorance, not of a sophisticated doping operation. Professional doping operations do not work that way.

What the case exposes is a different and less-named gap: the medical and legal support structure around East African distance runners. A world-class athlete, a Tokyo Marathon champion, handled her own defence by asking a family member to write a prescription. No specialist doping lawyer, no retroactive TUE process, nobody to tell her that admitting a treatment error would cost far less than constructing a fake file. The career death here came from missing counsel, not from a conspiracy.

And one more layer: how the substance gets named. When media call methylprednisolone a steroid, ordinary readers picture an athlete injecting muscle-building hormones. The reality is an anti-inflammatory used in joint treatment. That drift inflates the perceived severity of the substance side and quietly blurs the part that truly was severe: the forgery.

The pandemic summer taught me that what is buried deepest is sometimes what shows clearest. In this case, what was buried is the question of responsibility for the people standing around an athlete — the manager, the medical adviser, the national federation.

The six years have been handed down. But if the only lesson taken is do not forge documents, the system has learned nothing. I do not look for treasure where the lights are brightest. I shine a lamp into the dark corners others walk past — and the largest dark corner here is an elite athlete entirely alone once her file came under scrutiny.